|
1
|
Housman G, Byler S, Heerboth S, Lapinska
K, Longacre M, Snyder N and Sarkar S: Drug Resistance in Cancer: An
overview. Cancers (Basel). 6:1769–1792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kovalev AA, Tsvetaeva DA and Grudinskaja
TV: Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the
development of primary and acquired multiple drug resistance in
patients with early and metastatic breast cancer. Exp Oncol.
35:287–290. 2013.PubMed/NCBI
|
|
3
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Higgins CF: Multiple molecular mechanisms
for multidrug resistance transporters. Nature. 446:749–757. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nooter K, de la Riviere Brutel G, Look MP,
van Wingerden KE, Henzen-Logmans SC, Scheper RJ, Flens MJ, Klijn
JG, Stoter G and Foekens JA: The prognostic significance of
expression of the multidrug resistance-associated protein (MRP) in
primary breast cancer. Br J Cancer. 76:486–493. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Juranka PF, Zastawny RL and Ling V:
P-glycoprotein: Multidrug-resistance and a superfamily of
membrane-associated transport proteins. FASEB J. 3:2583–2592.
1989.PubMed/NCBI
|
|
7
|
Malavasi F, Funaro A, Roggero S,
Horenstein A, Calosso L and Mehta K: Human CD38: A glycoprotein in
search of a function. Immunol Today. 15:95–97. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jackson DG and Bell JI: Isolation of a
cDNA encoding the human CD38 (T10) molecule, a cell surface
glycoprotein with an unusual discontinuous pattern of expression
during lymphocyte differentiation. J Immunol. 144:2811–2815.
1990.PubMed/NCBI
|
|
9
|
Summerhill RJ, Jackson DG and Galione A:
Human lymphocyte antigen CD38 catalyzes the production of cyclic
ADP-ribose. FEBS Lett. 335:231–233. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zocchi E, Franco L, Guida L, Benatti U,
Bargellesi A, Malavasi F, Lee HC and De Flora A: A single protein
immunologically identified as CD38 displays NAD+
glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase
activities at the outer surface of human erythrocytes. Biochem
Biophys Res Commun. 196:1459–1465. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Howard M, Grimaldi JC, Bazan JF, Lund FE,
Santos-Argumedo L, Parkhouse RM, Walseth TF and Lee HC: Formation
and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen
CD38. Science. 262:1056–1059. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takasawa S, Tohgo A, Noguchi N, Koguma T,
Nata K, Sugimoto T, Yonekura H and Okamoto H: Synthesis and
hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and
inhibition of the hydrolysis by ATP. J Biol Chem. 268:26052–26054.
1993.PubMed/NCBI
|
|
13
|
Inageda K, Takahashi K, Tokita K, Nishina
H, Kanaho Y, Kukimoto I, Kontani K, Hoshino S and Katada T: Enzyme
properties of Aplysia ADP-ribosyl cyclase: Comparison with NAD
glycohydrolase of CD38 antigen. J Biochem. 117:125–131.
1995.PubMed/NCBI
|
|
14
|
Galione A: Ca(2+)-induced
Ca2+ release and its modulation by cyclic ADP-ribose.
Trends Pharmacol Sci. 13:304–306. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee HC: Cyclic ADP-ribose: A new member of
a super family of signalling cyclic nucleotides. Cell Signal.
6:591–600. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aarhus R, Graeff RM, Dickey DM, Walseth TF
and Lee HC: ADP-ribosyl cyclase and CD38 catalyze the synthesis of
a calcium-mobilizing metabolite from NADP. J Biol Chem.
270:30327–30333. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee HC: Physiological functions of cyclic
ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol
Toxicol. 41:317–345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berridge MJ, Bootman MD and Roderick HL:
Calcium signalling: Dynamics, homeostasis and remodelling. Nat Rev
Mol Cell Biol. 4:517–529. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smaili SS, Pereira GJ, Costa MM, Rocha KK,
Rodrigues L, do Carmo LG, Hirata H and Hsu YT: The role of calcium
stores in apoptosis and autophagy. Curr Mol Med. 13:252–265. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sulová Z, Seres M, Barancík M, Gibalová L,
Uhrík B, Poleková L and Breier A: Does any relationship exist
between P-glycoprotein-mediated multidrug resistance and
intracellular calcium homeostasis. Gen Physiol Biophys. 28:F89–F95.
2009.PubMed/NCBI
|
|
21
|
Florea AM and Büsselberg D: Anti-cancer
drugs interfere with intracellular calcium signaling.
Neurotoxicology. 30:803–810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pétriz J and García-López J: Flow
cytometric analysis of P-glycoprotein function using rhodamine 123.
Leukemia. 11:1124–1130. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Graeff RM, Walseth TF, Fryxell K, Branton
WD and Lee HC: Enzymatic synthesis and characterizations of cyclic
GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl
cyclase activity. J Biol Chem. 269:30260–30267. 1994.PubMed/NCBI
|
|
24
|
Yalcintepe L, Albeniz I, Adin-Cinar S,
Tiryaki D, Bermek E, Graeff RM and Lee HC: Nuclear CD38 in retinoic
acid-induced HL-60 cells. Exp Cell Res. 303:14–21. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grynkiewicz G, Poenie M and Tsien RY: A
new generation of Ca2+ indicators with greatly improved
fluorescence properties. J Biol Chem. 260:3440–3450.
1985.PubMed/NCBI
|
|
27
|
Zocchi E, Usai C, Guida L, Franco L,
Bruzzone S, Passalacqua M and De Flora A: Ligand-induced
internalization of CD38 results in intracellular Ca2+ mobilization:
Role of NAD+ transport across cell membranes. FASEB J. 13:273–283.
1999.PubMed/NCBI
|
|
28
|
Watson WD, Facchina SL, Grimaldi M and
Verma A: Sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitors
identify a novel calcium pool in the central nervous system. J
Neurochem. 87:30–43. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen JS, Agarwal N and Mehta K:
Multidrug-resistant MCF-7 breast cancer cells contain deficient
intracellular calcium pools. Breast Cancer Res Treat. 71:237–247.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gutheil JC, Hart SR, Belani CP, Melera PW
and Hussain A: Alterations in Ca2+ transport ATPase and
P-glycoprotein expression can mediate resistance to thapsigargin. J
Biol Chem. 269:7976–7981. 1994.PubMed/NCBI
|
|
31
|
Kellner U, Hutchinson L, Seidel A, Lage H,
Danks MK, Dietel M and Kaufmann SH: Decreased drug accumulation in
a mitoxantrone-resistant gastric carcinoma cell line in the absence
of P-glycoprotein. Int J Cancer. 71:817–824. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dürig J, Naschar M, Schmücker U,
Renzing-Köhler K, Hölter T, Hüttmann A and Dührsen U: CD38
expression is an important prognostic marker in chronic lymphocytic
leukaemia. Leukemia. 16:30–35. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guse AH: Regulation of calcium signaling
by the second messenger cyclic adenosine diphosphoribose (cADPR).
Curr Mol Med. 4:239–248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aksoy P, Escande C, White TA, Thompson M,
Soares S, Benech JC and Chini EN: Regulation of SIRT 1 mediated NAD
dependent deacetylation: A novel role for the multifunctional
enzyme CD38. Biochem Biophys Res Commun. 349:353–359. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Z and Chen W: Emerging roles of SIRT1
in cancer drug resistance. Genes Cancer. 4:82–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chu F, Chou PM, Zheng X, Mirkin BL and
Rebbaa A: Control of multidrug resistance gene mdr1 and cancer
resistance to chemotherapy by the longevity gene sirt1. Cancer Res.
65:10183–10187. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oh WK, Cho KB, Hien TT, Kim TH, Kim HS,
Dao TT, Han HK, Kwon SM, Ahn SG, Yoon JH, et al: Amurensin G, a
potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness
via down-regulation of multidrug resistance 1. Mol Pharmacol.
78:855–864. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Z, Liu Z, Wu X, Chu S, Wang J, Yuan
H, Roth M, Yuan YC, Bhatia R and Chen WY: ATRA-induced cellular
differentiation and CD38 expression inhibits acquisition of BCR-ABL
mutations for CML acquired resistance. PLoS Genet. 10:e10044142014.
View Article : Google Scholar : PubMed/NCBI
|
